US Diverts Pacific JASSM-ER Stocks to Iran; Cruise Missile Inventory Now Primary Constraint
JASSM-ER depletion from Pacific stocks creates a two-front procurement problem: Raytheon and Lockheed must simultaneously meet Central Command surge demand (immediate) and rebuild Pacific inventory (30-45 day lag).
This forces Pacific Command to either accept reduced precision-strike readiness against China during the next 6-8 weeks, or bid aggressively for priority production slots, driving up unit costs and delaying other programs (ATACMS, AGM-158C variants).
The reallocation also signals to Beijing that US precision-strike capacity is now a zero-sum competition between theaters—a deterrence liability if China interprets it as temporary weakness or as evidence that the US cannot sustain simultaneous high-intensity operations.
This signals that the US campaign against Iran is now constrained by munitions availability rather than targeting capacity.
Draining Pacific stocks exposes the Indo-Pacific theater to a 30-45 day resupply lag (typical JASSM-ER production lead time) and forces a choice: either accept degraded deterrence signaling toward China during a critical period, or accelerate production at plants already running at or near capacity.
Raytheon and Lockheed Martin (co-producers) will face competing demands from Central Command drawdown requests and Pacific replenishment orders simultaneously.
For defense investors, this reveals the true consumption rate of the Iran campaign and suggests either the conflict will extend beyond Trump's stated "final phase" timeline or precision-strike capacity will become the binding constraint on future operations—not air superiority or political will.
The article does not specify how many JASSM-ER rounds are in the total inventory, how many have already been expended in Operation Epic Fury, or what the current monthly production rate is.
Fault Lines
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.